SCHEMBL3567008

SCHEMBL3567008

CCCCC1(N(C)C)CCC2(CC1)c1[nH]c3ccccc3c1CCN2C(=O)Cc1ccc(OC)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.46
OGFRL1 Q5TC84 2/20 0.46
OPRL1 P41146 1/20 0.40
TRPV1 Q8NER1 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
ABCB1 P08183 1/20 0.37
ABCG2 Q9UNQ0 1/20 0.37
PTGDR2 Q9Y5Y4 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CDK8 P49336 1/20 0.37
NTRK3 Q16288 1/20 0.37
PARP14 Q460N5 1/20 0.36
KMT2A Q03164 1/20 0.36
HTT P42858 1/20 0.36
TRPA1 O75762 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3564709 0.82 OPRM1 (0.67) OPRM1OGFRL1OPRL1TRPV1ALDH1A1
SCHEMBL3559076 0.81 OPRM1 (0.52) OPRM1OGFRL1OPRL1TRPV1ALDH1A1
SCHEMBL10038860 0.81 OPRM1 (0.56) OPRM1OGFRL1OPRL1ALDH1A1LMNA
SCHEMBL516914 0.81 OPRM1 (0.56) OPRM1OGFRL1OPRL1ALDH1A1LMNA
SCHEMBL516922 0.81 OPRM1 (0.56) OPRM1OGFRL1OPRL1ALDH1A1LMNA
SCHEMBL3566282 0.81 OPRM1 (0.47) OPRM1OGFRL1OPRL1TRPV1ALDH1A1
SCHEMBL699664 0.80 OPRM1 (0.44) OPRM1OGFRL1OPRL1TRPV1ALDH1A1
SCHEMBL3562890 0.80 OPRM1 (0.54) OPRM1OGFRL1OPRL1TRPV1ALDH1A1
SCHEMBL3570170 0.78 OPRM1 (0.52) OPRM1OGFRL1OPRL1TRPV1ALDH1A1
SCHEMBL3570168 0.78 OPRM1 (0.52) OPRM1OGFRL1OPRL1TRPV1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121689-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-07-31 EP claimed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US claimed
EP-2121689-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-07-31 EP disclosed
EP-2121689-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-07-31 EP disclosed
US-8404740-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2013-03-26 US disclosed
US-8404740-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2013-03-26 US disclosed
US-8404740-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2013-03-26 US disclosed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
WO-2008101659-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048554-A1 Spirocyclic Cyclohexane Compounds OPRL1, OPRD1, OPRK1 OPRM1 4/4885OGFRL1 5/4885OPRL1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.